CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
0.70
-0.03 (-4.62%)
At close: May 07, 2025, 3:59 PM
0.68
-2.42%
After-hours: May 07, 2025, 05:14 PM EDT
-4.62% (1D)
| Bid | 0.65 |
| Market Cap | 3.89M |
| Revenue (ttm) | 1.16M |
| Net Income (ttm) | -11.09M |
| EPS (ttm) | -40.29 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.79 |
| Volume | 516,623 |
| Avg. Volume (20D) | 1,811,318 |
| Open | 0.72 |
| Previous Close | 0.73 |
| Day's Range | 0.68 - 0.73 |
| 52-Week Range | 0.53 - 130.50 |
| Beta | 0.68 |
About CERO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+38.85%
CERo Therapeutics Holdings shares are trading high...
Unlock content with
Pro Subscription
5 months ago
+7.68%
CERo Therapeutics Holdings shares are trading higher after the company received FDA clearance to initiate Phase 1 trials of its lead compound, CER-1236
